AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology.
AROC | ST
Overview
Corporate Details
- ISIN(s):
- SE0003883990
- LEI:
- 549300RF3VQBLGOJ7J46
- Country:
- Sweden
- Address:
- Karlsbodavägen 39, 168 67 Bromma
- Website:
- https://arocell.com/
- Sector:
- Manufacturing
Description
IDL Diagnostics AB, formerly AroCell AB, is a diagnostics company that develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology. The company's portfolio aims to provide high-value clinical information for disease detection, prognosis, and monitoring. Key products in oncology include the TK 210 ELISA, a cell proliferation biomarker for assessing therapy response in various cancers, and the UBC® Rapid, a point-of-care test for bladder cancer. In bacteriology, the company provides the TUBEX® TF rapid test for the detection of acute typhoid fever. IDL Diagnostics also licenses tumor markers to strategic partners.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AroCell AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AroCell AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AroCell AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
